- Home
- CFFN vs SGP Comparison
CFFN vs SGP Comparison
Compare CFFN & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFFN | SGP |
|---|---|---|
| Founded | 1893 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 981.1M | 932.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CFFN | SGP |
|---|---|---|
| Price | $7.53 | $23.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $7.25 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 869.4K | 49.1K |
| Earning Date | 04-29-2026 | 05-15-2026 |
| Dividend Yield | ★ 4.51% | N/A |
| EPS Growth | ★ 79.31 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $16,300,000.00 | N/A |
| Revenue This Year | $20.16 | N/A |
| Revenue Next Year | $6.62 | N/A |
| P/E Ratio | $23.80 | ★ N/A |
| Revenue Growth | ★ 6.54 | N/A |
| 52 Week Low | $5.51 | $20.15 |
| 52 Week High | $7.97 | $30.56 |
Technical Indicators
Market Signals| Indicator | CFFN | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 44.29 |
| Support Level | $7.47 | $20.95 |
| Resistance Level | $7.85 | $26.29 |
| Average True Range (ATR) | 0.16 | 1.47 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 17.00 | 38.44 |
Price Performance
Historical ComparisonAbout CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.